Company: PFSA
Filing Date: 2025-10-09
Form Type: S-1
Source: 0001213900-25-097860
Chunk: 214

Company: Profusa, Inc.
Filing Date: 2025-10-09
Form: S-1
Chunk 214
---
 than the principal executive officer whose total compensation for 2024 exceeded $100,000, who were serving as executive officers as of December 31, 2024. We refer to these individuals as “named executive officers.” For 2024, Ben Hwang, Chief Executive Officer and Chairman, was Profusa’s only “named executive officer.” Compensation of Named Executive Officer Cash Compensation Base salaries are intended to provide a level of compensation sufficient to attract and retain an effective management team, when considered in combination with the other components of the executive compensation program. In general, Profusa provides a base salary level designed to reflect the executive officer’s scope of responsibility and accountability. While cash bonuses have been provided on a discretionary basis in prior years, Dr. Hwang did not receive a cash bonus with respect to 2024. Equity Awards While Profusa maintains an equity compensation plan, during 2024, Dr. Hwang did not receive any equity awards with respect to Profusa and, as of December 31, 2024, Dr. Hwang did not hold any outstanding equity awards with respect to Profusa. Summary Compensation Table The following table shows information regarding the compensation of Dr. Hwang, our sole named executive officer, for services performed in the years ended December 31, 2024 and 2023.

| Name and Principal Position          |     | Year |      |     | Salary 
 ($)    |         |     | Bonus 
 ($)   |   |     | Option 
 Awards 
 ($)(1) |   |     | Stock  
 Awards 
 ($)    |   |     | Non-Equity     
 Incentive Plan 
 Compensation   
 ($)            |   |     | All Other    
 Compensation 
 ($)          |   |     | Total 
 ($)   |         |
| Ben Hwang                            |     |      | 2024 |     |        | 470,000 |     |       | — |     |        | — |     |        | — |     |                | — |     |              | — |     |       | 470,000 |
| Chief Executive Officer and Chairman |     |      | 2023 |     |        | 470,000 |     |       | — |     |        | — |     |        | — |     |                | — |     |              | — |     |       | 470,000 |

Outstanding Equity Awards at 2023 Fiscal Year-End As of December 31, 2024, Dr. H